Skip to main content

CRESCENT BIOPHARMA, INC. insider trading

CBIONASDAQ
$14.32+0.06 (+0.42%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+19.0%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flow

Key players

  • BGBVF GP Holdings LLC10% OwnerNot reportedof company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
CBIOJoshua T. BrummChief Executive OfficerOpen market sell$131K-2.8%$16.71$131KSep 18, 2026Sep 18, 2026
CBIOJonathan McNeillPresident and COOOpen market sell$64.1K-2.8%$16.71$64.1KSep 18, 2026Sep 18, 2026
CBIORyan LynchSee RemarksOpen market sell$4.3K-1.7%$17.90$4.3KSep 16, 2026Sep 18, 2026
CBIOJan PinkasChief Scientific OfficerOpen market sell$11.8K-3.0%$17.90$11.8KSep 16, 2026Sep 18, 2026
CBIOEllie Eunkyung ImChief Medical OfficerOpen market sell$11.2K-2.8%$17.90$11.2KSep 16, 2026Sep 18, 2026
CBIORichard William ScalzoChief Financial OfficerOpen market sell$10.2K-2.8%$17.90$10.2KSep 16, 2026Sep 18, 2026
CBIOBarbara Harlin BisphamSee RemarksOpen market sell$11.1K-3.2%$17.90$11.1KSep 16, 2026Sep 18, 2026
CBIOJoshua T. BrummChief Executive OfficerOpen market sell$28.8K-0.6%$17.90$28.8KSep 16, 2026Sep 18, 2026
CBIOJonathan McNeillPresident and COOOpen market sell$13.1K-0.5%$17.90$13.1KSep 16, 2026Sep 18, 2026
CBIOFairmount Funds Management LLCDirectorOpen market purchase$12.4M+31.1%$14.50$12.4MJul 16, 2026Jul 20, 2026
CBIORyan LynchSee RemarksOpen market sell$8.37K-3.2%$17.99$8.37KJun 22, 2026Jun 23, 2026
CBIOJan PinkasChief Scientific OfficerOpen market sell$23.2K-5.5%$17.99$23.2KJun 22, 2026Jun 23, 2026
CBIORichard William ScalzoChief Financial OfficerOpen market sell$20K-5.2%$17.99$20KJun 22, 2026Jun 23, 2026
CBIOBarbara Harlin BisphamSee RemarksOpen market sell$21.9K-5.9%$17.99$21.9KJun 22, 2026Jun 23, 2026
CBIOEllie Eunkyung ImChief Medical OfficerOpen market sell$21.9K-5.2%$17.99$21.9KJun 22, 2026Jun 23, 2026
CBIOJonathan McNeillPresident and COOOpen market sell$370K-12.9%$17.99$370KJun 22, 2026Jun 23, 2026
CBIOJoshua T. BrummChief Executive OfficerOpen market sell$761K-13.1%$17.99$761KJun 22, 2026Jun 23, 2026
CBIOPeter Evan HarwinDirectorOpen market purchase$18.2M+98.0%$13.41$18.2MDec 4, 2025Dec 8, 2025
End of history · 18 transactions

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.